Why the study?
Does NT-proBNP measurement have diagnostic value for chronic heart failure in patients with type 2 diabetes mellitus?
Observational (n=60)
Does NT-proBNP measurement have diagnostic value for chronic heart failure in patients with type 2 diabetes mellitus?
NT-proBNP measurement is valuable for diagnosing chronic heart failure in patients with type 2 diabetes, but it has low specificity for assessing the functional severity of the disease.
Detction of chronic heart failure at the stage of reversible changes can prevent the development of cardiovascular complications, reduce morbidity and mortality in patients with type 2 diabetes mellitus. The aim of our study was to explore the level of N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) and to evaluate the possibility of using this marker in diagnostics of chronic heart failure in patients with type 2 diabetes. The study included 60 patients with type 2 diabetes and concomitant chronic heart failure. All patients underwent echocardiography, blood glucose and glycated hemoglobin, creatinine, and NT-proBNP measurement. All patients with diabetes mellitus were shown to have elevated NT-proBNP levels in comparison with the control group. We established negative correlation of this parameter with the left ventricular ejection fraction and inverse correlation between NT-proBNP and blood glucose. The study confirmed the value of NT-proBNP measurement for diagnostics of CHF but demonstrated low specificity of this test for the assessment of severity (functional class) of CHF in patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Verbovoy et al. (2017) conducted an observational in Type 2 diabetes mellitus and chronic heart failure (n=60). NT-proBNP measurement vs. Control group was evaluated on NT-proBNP levels and correlation with left ventricular ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: